Cargando…
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial
INTRODUCTION: In early breast cancer, neoadjuvant chemotherapy (NACT) is increasingly used. The proof of efficacy is pathologically complete response (pCR), i.e. the absence of invasive tumour in breast and lymph nodes at surgery. Today, pCR is a common endpoint in pharmaceutical trials since it is...
Autores principales: | de Boniface, Jana, Altena, Renske, Haddad Ringborg, Cecilia, Bolam, Kate A., Wengström, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562167/ https://www.ncbi.nlm.nih.gov/pubmed/36227931 http://dx.doi.org/10.1371/journal.pone.0274804 |
Ejemplares similares
-
Distance-based delivery of exercise for people treated for breast, prostate or colorectal cancer: a study protocol for a randomised controlled trial of EX-MED Cancer Sweden
por: Kotte, Melissa, et al.
Publicado: (2023) -
Long-Term Favorable Effects of Physical Exercise on Burdensome Symptoms in the OptiTrain Breast Cancer Randomized Controlled Trial
por: Wiggenraad, Fleur, et al.
Publicado: (2020) -
High intensity exercise during breast cancer chemotherapy - effects on long-term myocardial damage and physical capacity - data from the OptiTrain RCT
por: Ansund, Josefin, et al.
Publicado: (2021) -
Effects of Exercise on Chemotherapy Completion and Hospitalization Rates: The OptiTrain Breast Cancer Trial
por: Mijwel, Sara, et al.
Publicado: (2019) -
Two-year follow-up of the OptiTrain randomised controlled exercise trial
por: Bolam, Kate A., et al.
Publicado: (2019)